Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Galapagos, Eli Lilly, GlaxoSmithKline deal

GLPG and LLY partnered to discover compounds against 12 GLPG targets to treat osteoporosis. GLPG is responsible for developing compounds through Phase IIa testing, after which LLY will

Read the full 286 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE